论文部分内容阅读
目的对社区慢性病老年人的用药安全情况及相关干预措施予以探究。方法 138例患有慢性病且长期服药的老年患者,随机分为对照组与观察组,每组69例。其中对照组给予常规统一的药物知识宣传教育,观察组在对照组基础上进行深入随访,对受访老年人进行有针对性的用药指导,对比分析两组患者药物认知情况、用药依从性及用药疗效。结果干预后,两组患者的药物认知情况较干预前均显著改善,且观察组患者的药物认知情况显著优于对照组,差异具有统计学意义(P<0.05)。干预后,两组患者的用药依从性均显著高于干预前,且观察组患者的用药依从性显著高于对照组,差异具有统计学意义(P<0.05)。观察组患者用药后的治疗总有效率(95.65%)显著高于对照组(82.61%),差异具有统计学意义(P<0.05)。结论对社区慢性病老年患者予以深入宣传教育与随访,有针对性地对其进行用药指导,可显著改善用药安全情况,增强药物疗效。
Objective To explore the medication safety of elderly people with chronic diseases in the community and related interventions. Methods A total of 138 elderly patients with chronic diseases and long-term medication were randomly divided into control group and observation group, with 69 cases in each group. The control group was given routine and uniform drug knowledge publicity and education. The observation group conducted in-depth follow-up on the basis of the control group and conducted targeted medication guidance on the aged patients. The cognition, drug compliance, Medication efficacy. Results After intervention, the drug cognition of both groups improved significantly compared with those before intervention, and the cognition of the patients in the observation group was significantly better than that of the control group (P <0.05). After intervention, medication adherence of both groups was significantly higher than before intervention, and medication compliance of observation group was significantly higher than that of control group, the difference was statistically significant (P <0.05). The total effective rate of treatment group (95.65%) after treatment was significantly higher than that of control group (82.61%), the difference was statistically significant (P <0.05). Conclusions In-depth publicity, education and follow-up of elderly patients with chronic diseases in the community and targeted medication guidance can significantly improve medication safety and enhance drug efficacy.